fashion -WSS

fashion

author：fashion 2025-09-14 08:21:12 - browse：32616

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： BMS, looking to build heart drug business, turns to AI for diagnosis

WSS

Mark Cuban is blaming the wrong people for high drug costs

Illinois Supreme Court finds assault weapons ban constitutional

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

RaDonda Vaught case: a double standard for nurses, physicians

Novo Nordisk touts Wegovy study, but still struggling with supply

Make 'food is medicine' a key part of White House nutrition meeting

entertainment

fashion

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Listen: Biogen's messy board & Laronde's data problem

BioMarin wins approval for gene therapy to treat hemophilia A

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Affirmative action in medical school literally saved lives

YouTube cracks down on misinformation on cancer treatment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Illumina slashes 2023 revenue projections yet again

Novavax promises a turnaround & Lilly roils the obesity market

Community addresses injustice for Long Island mothers

focus

Novo Nordisk touts Wegovy study, but still struggling with supply

Be careful with at

Australia's humpback populations rebound raising hopes of marine scientists

Doctor appointment wait times are getting worse

Mark Cuban is blaming the wrong people for high drug costs

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

explore

focus

leisure time

leisure time